Multi-institutional survey of malignant pleural mesothelioma patients in the Hokushin region

J Cancer Res Clin Oncol. 2022 May;148(5):1153-1158. doi: 10.1007/s00432-021-03699-z. Epub 2021 Jun 29.

Abstract

Background: Malignant pleural mesothelioma (MPM) is a major occupational and environmental neoplasm. The purpose of this study was to validate the clinical and epidemiological factors, diagnosis, and initial treatment among MPM patients in the Hokushin region.

Methods: We surveyed retrospective data from 152,921 cancer patients in 22 principal hospitals.

Results: A total of 166 MPM cases were newly diagnosed. These patients consisted of 136 men and 30 women, with a median age of 69 years. We estimated the incidence rate for MPM to be 0.55 cases per 100,000 person-years in this study. The ratio per 100,000 population-years was 0.39 in Fukui, 0.60 in Ishikawa, 1.02 in Toyama and 0.35 in Nagano. Forty-five patients were discovered when diagnosed incidentally in patients under observations for other diseases. Forty-six cases were diagnosed as localized disease, while 13 had accompanying regional lymph node metastasis. Furthermore, 44 cases showed infiltration into adjacent organs. A histo-cytological diagnosis was made in 164 cases (98.8%). A surgical approach, chemotherapy, and radiotherapy were performed for 33, 88, and 6 patients, respectively, while 44 patients (26.5%) received best supportive care. Multimodality therapy was conducted in just 3.0% of the MPM patients CONCLUSION: MPM has a tragically rapid progression if discovered under observations for other diseases. Workers in health-related fields should be on high alert for aggressive MPM. Better evaluation and multi-disciplinary approaches to MPM in these regions are needed to optimize multimodality therapy.

Keywords: Cancer registration; Cancer screening; Ganpro database; Hokushin region; Malignant pleural mesothelioma.

Publication types

  • Multicenter Study

MeSH terms

  • Aged
  • Female
  • Humans
  • Incidence
  • Lung Neoplasms* / diagnosis
  • Lung Neoplasms* / epidemiology
  • Lung Neoplasms* / therapy
  • Male
  • Mesothelioma* / epidemiology
  • Mesothelioma* / therapy
  • Mesothelioma, Malignant*
  • Pleural Neoplasms* / epidemiology
  • Pleural Neoplasms* / therapy
  • Retrospective Studies